Isolated Limb Perfusion for Stage III Melanoma: Does It Still Have a Role in the Present Era of Effective Systemic Therapy?Dirk J. Grünhagen, MD, PhD, and Cornelis Verhoef, MD, PhD
Effective systemic therapy for the treatment of stage III melanoma has emerged. Whether this influences treatment choice in stage III melanoma patients with in-transit metastases is the subject of this review.
December 2016 Table of Contents
Volume 30 | Number 12
Breast Cancer Following Radiation for Hodgkin Lymphoma: Clinical Scenarios and Risk-Reducing Strategies
Linda Overholser, MD, MPH, Elena Shagisultanova, MD, PhD, Rachel A. Rabinovitch, MD, et al
Treatment of Acute Lymphoblastic Leukemia in Adults: Applying Lessons Learned in Children
Ibrahim T. Aldoss, MD, Guido Marcucci, MD, and Vinod Pullarkat, MD
Isolated Limb Perfusion for Stage III Melanoma: Does It Still Have a Role in the Present Era of Effective Systemic Therapy?
Dirk J. Grünhagen, MD, PhD, and Cornelis Verhoef, MD, PhD
ACR Appropriateness Criteria® Recurrent Hodgkin Lymphoma
Karen M. Winkfield, MD, PhD, Ranjana H. Advani, MD, Leslie K. Ballas, MD, et al
Metastatic Papillary Adenocarcinoma in a 22-Year-Old: Is Her History of Mayer-Rokitansky-Küster-Hauser Syndrome Causative or Incidental?
Regina J. Brown, MD, Joshua H. Petit, MD, Lars Widdel, MD, et al
The Heartaches of Cancer Therapy: Acute and Late Cardiotoxicity in Cancer Survivors
Saurin Chokshi, MD, Jeremy Jacox, PhD, Sarah C. Hull, MD, MBE, and Tara Sanft, MD
POINT: The Role of Stem Cell Transplantation in Mantle Cell Lymphoma
Andre Goy, MD, MS